News and Press Releases

Two Weeks to Go – London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, Disruptive Tech, Emerging Innovators

2 June 2025 -- London, UK -- In just two weeks, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one...

Category: BioManufacturing, Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: June 2, 2025

Chemspec Europe 2025 opens next week: Europe’s top event for fine and speciality chemicals set for strongest edition to date

30 May 2025 -- Koelnmesse, Germany -- From 4–5 June, thousands of industry professionals will gather in Cologne for the 38th edition of Chemspec Europe – the leading marketplace for fine...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: May 30, 2025

Koelnmesse, Germany

Attend Europe’s leading vaccine event!

World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 27, 2025

Big names, big issues: Chemspec Europe 2025 to deliver strong insights and momentum at a pivotal time for the chemicals industry

22 May 2025 -- Koelnmesse, Germany -- From 4–5 June, the international fine and speciality chemicals industry will gather at Koelnmesse, Germany, for the 38th edition of Chemspec Europe –...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 22, 2025

Koelnmesse, Germany

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

12 May 2025 -- Leiden, the Netherlands and Massachusetts, US -- ProQR Therapeutics NV (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: May 15, 2025

Zernikedreef 9 2333 CK Leiden The Netherlands

Quidditas raises €2.62M to accelerate development of pioneering genome editing technology

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction and...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: May 12, 2025

23, rue des bourguignons 91310 MONTLHERY

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF)  Regulatory and strategic...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 1, 2025

PureTech Health 6 Tide Street Boston, MA 02210

Iksuda to present growing ADC pipeline at AACR

Introduces the ProAlk payload series to address the growing challenge of ADC sequencing IKS04 to enter clinical development for gastrointestinal cancers by end of 2025 PermaLink offers stable and scalable...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 25, 2025

The Biosphere, Draymans Way, Newcastle Helix Newcastle upon Tyne NE4 5BX

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform

Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development 24 April 2025 -- Cambridge, UK -- CN Bio,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 24, 2025

30 Upper High Street, Thame, Oxfordshire, OX9 3EZ

Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers

23 April 2025 -- Ingelheim, Germany and Amsterdam, the Netherlands -- Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2025

Binger Strasse 173 55216 Ingelheim am Rhein

ChinaBio Partnering Forum 2025: Connecting China’s Biotech Innovations with the Global Life Science Ecosystem

1 April 2025 -- Shanghai, China -- ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, returns in 2025 with a hybrid format to facilitate...

Category: Biotechnology, Other, Pharmaceutical
Posted: April 1, 2025

Kerry Hotel Pudong, Shanghai No. 1388, Hua mu Road, Pudong, Shanghai, 201204 China

Industry Leaders Address Future of Oncology Drugs and Biotech Funding at AAPS National Biotechnology Conference

Registration Now Open 26 March 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 National Biotechnology Conference (NBC), taking place...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2025

Central Research Laboratories Launches Single-Use Gamma Bags for Biopharma and Life Sciences Applications

25 March 2025 -- Minnesota, US -- Central Research Laboratories (CRL), a global leader in the remote-handling industry, is launching Single-Use Gamma Bags that have been designed to undergo gamma-sterilization...

Category: Biotechnology, Logistics, Other, Pharmaceutical
Posted: March 25, 2025

3965 Pepin Avenue Red Wing, MN 55066

ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025

Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May 25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 25, 2025

ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

19 March 2025 -- Dublin, Ireland & New Jersey, US -- Amarin Corporation plc today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 24, 2025

88 Harcourt Street, Dublin 2, Ireland